Renal Denervation Effects on Blood Pressure in Resistant and Uncontrolled Hypertension: A Meta‐Analysis of Sham‐Controlled Randomized Clinical Trials
Clinical Cardiology2025Vol. 48(3), pp. e70104–e70104
Citations Over TimeTop 10% of 2025 papers
Hamidreza Soleimani, Babak Sattartabar, Bahar Parastooei, Reza Eshraghi, Roozbeh Nazari, Soroush Najdaghi, Sara Hobaby, Ali Etemadi, Mehrdad Mahalleh, Maryam Taheri, Adrían V. Hernández, Toshiki Kuno, Homa Taheri, Robert J. Siegel, Florian Rader, Behnam Tehrani, Mohammad Hossein Mandegar, Ehsan Safaee, Pouya Ebrahimi, Kaveh Hosseini
Abstract
RDN significantly reduced several SBP and DBP outcomes versus sham without significantly increasing complications. This makes RDN a potentially effective alternative to medications in URH.
Related Papers
- → Renal Denervation for Resistant Hypertension?(2014)64 cited
- → Eligibility for Renal Denervation in Patients With Resistant Hypertension(2012)50 cited
- → Impact of renal denervation on 24-hour blood pressure pattern in patients with resistant hypertension(2019)5 cited
- → TCT-416 Renal Denervation for the Management of Resistant Hypertension: A Meta-Analysis(2014)
- → Renal Denervation Improves Systolic Ambulatory BP in Resistant Hypertension(2014)